Advanced Enzyme's board proposes a final dividend of INR 1.35 per share, pending approval at the company's annual general meeting.
Advanced Enzyme Technologies Limited
ADVENZYMESPrice History
Recent Discussions
Advanced Enzyme's Q4 EBITDA significantly increased by 38%, reaching approximately $8.6 million, compared to last year. The firm's profit margins also expanded notably, rising to 31.1%.
Today, Blue Dart, Birla Corporation, Gujarat Ambuja Exports, Atlanta Electricals, ASM Tech, Advanced Enzyme, and Sambhv Steel Tubes are set to reveal their Q4 financial results, providing investors with insights into their recent performance.
Advanced Enzyme's Q4 net profit increased significantly by 63%, reaching ₹43 crores, while revenue grew by 9% to ₹203.3 crores. However, the company's EBITDA decreased by 3.8%, and the margin dropped from 35% to 31% year-over-year.
Advanced Enzyme Technologies announced a proposed dividend of INR 1.35 per share for the fiscal year 2025-26, subject to approval at the AGM. The company also reappointed Mr. Mukund Kabra as Whole-Time Director and approved an equity allotment under ESOP, increasing their capital to approximately INR 22.4 crore.
Advanced Enzyme Technologies maintains a strong credit rating, according to CRISIL, with long-term 'A Stable' and short-term 'A1'. A total of Rs. 100 crore in bank loan facilities have been rated, further details can be found on the company's website.
Advanced Enzymes will review its Q4 FY26 financial results during their board meeting on May 9th, 2026. The trading window is closed until May 11th for any potential announcements regarding this matter. For updates, visit the company's official website at advancedenzymes.com.